tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Gerberry, 175 are a BUY (66.29%), 59 are a HOLD (22.35%), 30 are a SELL (11.36%).
Analyst Jason Gerberry, currently employed at BAML, carries an average stock price target met ratio of 63.51% that have a potential upside of 30.31% achieved within 287 days.
Jason Gerberry’s has documented 552 price targets and ratings displayed on 52 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EXEL, Exelixis at 05-Jun-2025.
Analyst best performing recommendations are on CORI (CORIUM INTERNATIONAL).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $261 was fulfilled within 2 days with a profit of $32.55 (14.25%) receiving and performance score of 71.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$205
$13.92 (7.28%)
$215
1 months 2 days ago
(14-May-2025)
12/14 (85.71%)
$27.59 (15.55%)
285
Buy
$216
$24.92 (13.04%)
$214
1 months 18 days ago
(29-Apr-2025)
23/26 (88.46%)
$22.49 (11.62%)
431
Buy
$250
$58.92 (30.84%)
$241
1 months 19 days ago
(28-Apr-2025)
12/18 (66.67%)
$57.66 (29.98%)
526
Buy
$240
$48.92 (25.60%)
$210
3 months 11 days ago
(05-Mar-2025)
7/8 (87.5%)
$28.46 (13.45%)
474
Hold
$223
$31.92 (16.71%)
$191
3 months 12 days ago
(04-Mar-2025)
3/4 (75%)
$15.71 (7.58%)
443
Which stock is Jason Gerberry is most bullish on?
Which stock is Jason Gerberry is most reserved on?
What Year was the first public recommendation made by Jason Gerberry?
